We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+22.62%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.77B
AUM Growth
+$282M
Cap. Flow
+$179M
Cap. Flow %
10.07%
Top 10 Hldgs %
30.07%
Holding
2,442
New
714
Increased
405
Reduced
476
Closed
723

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.9M
2
FDC
First Data Corporation
FDC
+$23.8M
3
ULTI
Ultimate Software Group Inc
ULTI
+$17.6M
4
CNC icon
Centene
CNC
+$16.8M
5
LXFT
Luxoft Holding, Inc.
LXFT
+$14.3M

Top Sells

Rank Stock Value
1
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
+$47.3M
2
SHPG
Shire pic
SHPG
+$43.4M
3
P
Pandora Media Inc
P
+$25.4M
4
IMPV
Imperva, Inc.
IMPV
+$19.5M
5
ATHN
Athenahealth, Inc.
ATHN
+$17.1M

Sector Composition

Rank Sector Weight
1 Technology 7.8%
2 Healthcare 6.74%
3 Communication Services 5.4%
4 Consumer Discretionary 5.34%
5 Real Estate 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSTG
1651
DELISTED
NanoString Technologies, Inc.
NSTG
$4K ﹤0.01%
178
-3,366
-95% -$77.3K
RAD
1652
PUT
DELISTED
Rite Aid Corporation
RAD
$4K ﹤0.01%
300
– –
OBSV
1653
DELISTED
ObsEva SA Ordinary Shares
OBSV
$4K ﹤0.01%
290
-17
-6% -$219
XENT
1654
DELISTED
Intersect ENT, Inc
XENT
$4K ﹤0.01%
+126
New +$3.9K
MDR
1655
CALL
DELISTED
McDermott International
MDR
$4K ﹤0.01%
500
-2,600
-84% -$21.4K
AVDR
1656
DELISTED
Avedro, Inc Common Stock
AVDR
$4K ﹤0.01%
+315
New +$3.94K
BC icon
1657
Brunswick
BC
$5.28B
$3K ﹤0.01%
+61
New +$3.08K
GEOS icon
1658
Geospace Technologies
GEOS
$75.7M
$3K ﹤0.01%
+200
New +$2.92K
MANH icon
1659
Manhattan Associates
MANH
$11.4B
$3K ﹤0.01%
49
-1,170
-96% -$59.8K
NVR icon
1660
NVR
NVR
$17B
$3K ﹤0.01%
1
-11
-92% -$28.9K
PCTY icon
1661
Paylocity
PCTY
$7.98B
$3K ﹤0.01%
+35
New +$2.72K
RCKT icon
1662
Rocket Pharmaceuticals
RCKT
$394M
$3K ﹤0.01%
158
+3
+2% +$47
RGEN icon
1663
Repligen
RGEN
$9.25B
$3K ﹤0.01%
45
-64
-59% -$3.68K
TEVA icon
1664
CALL
Teva Pharmaceuticals
TEVA
$41.2B
$3K ﹤0.01%
+200
New +$3.53K
TLRY icon
1665
Tilray
TLRY
$622M
$3K ﹤0.01%
5
– –
BBBY
1666
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
$3K ﹤0.01%
200
-40,700
-100% -$615K
FBM
1667
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$3K ﹤0.01%
+300
New +$2.91K
OMN
1668
DELISTED
OMNOVA Solutions Inc.
OMN
$3K ﹤0.01%
400
-19,184
-98% -$153K
AXDX
1669
CALL
DELISTED
Accelerate Diagnostics
AXDX
$2K ﹤0.01%
10
– –
FENC icon
1670
Fennec Pharmaceuticals
FENC
$402M
$2K ﹤0.01%
+315
New +$2.07K
GDS icon
1671
GDS Holdings
GDS
$6.41B
$2K ﹤0.01%
43
-4,957
-99% -$150K
KPTI icon
1672
Karyopharm Therapeutics
KPTI
$48M
$2K ﹤0.01%
21
-3
-13% -$333
OI icon
1673
O-I Glass
OI
$1.08B
$2K ﹤0.01%
+121
New +$2.35K
RFIL icon
1674
RF Industries
RFIL
$139M
$2K ﹤0.01%
228
-15,485
-99% -$116K
RYZ
1675
Ryerson Holding Corp
RYZ
$1.46B
$2K ﹤0.01%
+200
New +$1.55K
65 66
67
68 69

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Prelude Capital Management held 2,442 positions worth $1.77B, up 19% from $1.49B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Prelude Capital Management deployed $179M of net new capital in Q1 2019, opening 714 new positions and adding to 405 existing holdings. Its largest new stake was Ultimate Software Group Inc: 57,473 shares worth $19M.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, down from 12% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Integrated Device Technology I, an estimated $12.7M trimmed.

  • Prelude Capital Management's largest Q1 2019 buy was Ultimate Software Group Inc: 57,473 shares worth $19M.
  • Prelude Capital Management added most to Celgene Corp in Q1 2019, an estimated $43.9M increase.
  • Prelude Capital Management's biggest Q1 2019 reduction was Integrated Device Technology I, cutting an estimated $12.7M.
  • Prelude Capital Management fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $47.3M.
  • Prelude Capital Management's ten largest holdings make up 30% of its $1.77B portfolio in Q1 2019.
  • Prelude Capital Management opened 714 new positions and closed 723 in Q1 2019.
  • Prelude Capital Management's portfolio value rose 19% quarter-over-quarter to $1.77B.

Based on Prelude Capital Management's 13F filing for Q1 2019, filed 15 May 2019.